Company search
Overview
Performance
Portfolio
ESG
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Unlisted holdings
| % of total assets |
|---|
| N/R |
Please note that the percentage of unlisted holdings is displayed for companies that have reported this data to the AIC. “N/R” means the data has not been reported to the AIC. Where data is reported, it may be subject to valuation lags.
Top holdings
Data as at : 30/09/2023
| Investment | % of total assets |
|---|---|
| Quell Therapeutics Limited | 7.3 |
| SwanBio Therapeutics Limited | 6.4 |
| Beacon Therapeutics Holdings Limited1 | 6.2 |
| Anaveon AG | 5.4 |
| Autolus Therapeutics plc | 5.3 |
| OMass Therapeutics Limited | 3.6 |
| Resolution Therapeutics Limited | 3.2 |
| Purespring Therapeutics Limited | 2.9 |
| Clade Therapeutics Inc | 2.0 |
| Cambridge Epigenetix Limited | 1.6 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
